Acadia Pharmaceuticals (ACAD) PT Raised to $33 at H.C. Wainwright, "may bolster trofinetide’s footprint globally"
Tweet Send to a Friend
(Updated - July 14, 2023 6:35 AM EDT)
H.C. Wainwright analyst Andrew S. Fein raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Andrew S. Fein raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
